Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Guitart
607 Anti-Pruritic Properties of Remetinostat (SHAPE), a Topical Histone Deacetylase Inhibitor (HDACi); Data From a Randomized Phase 2 Study in Patients With Stage IA- IIA Mycosis Fungoides
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Related publications
Preclinical Anti-Arthritic Study and Pharmacokinetic Properties of a Potent Histone Deacetylase Inhibitor MPT0G009
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Phase I Study of Anti-Vegf Monoclonal Antibody Bevacizumab and Histone Deacetylase Inhibitor Valproic Acid in Patients With Advanced Cancers
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Solar: A Phase 2, Global, Randomized, Active Comparator Study to Investigate the Efficacy and Safety of Cobomarsen in Subjects With Mycosis Fungoides (Mf)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Risk of Cutaneous Malignancy in Mycosis Fungoides Patients Treated With PUVA: A Retrospective Study
Turk Dermatoloji Dergisi
Dermatology
Efficacy of Narrowband UVB vs. PUVA in Patients With Early-Stage Mycosis Fungoides
Journal of the European Academy of Dermatology and Venereology
Dermatology
Infectious Diseases
A Phase I Study of Intravenous LBH589, a Novel Cinnamic Hydroxamic Acid Analogue Histone Deacetylase Inhibitor, in Patients With Refractory Hematologic Malignancies
Clinical Cancer Research
Cancer Research
Oncology
106 Early Stage Mycosis Fungoides Has a Mutanome Distinct From Sezary Syndrome
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Complex Structure of a Bacterial Class 2 Histone Deacetylase Homologue With a Trifluoromethylketone Inhibitor
Acta Crystallographica Section F Structural Biology and Crystallization Communications
A Novel Histone Deacetylase Inhibitor, CKD5, Has Potent Anti-Cancer Effects in Glioblastoma
Oncotarget
Oncology
